Purpose Ultrahypofractionationed radiation therapy for prostate cancer is increasingly
studied and adopted. The American Association of Physicists in Medicine Working Group on …

Normal tissue complication probability (NTCP) models that were formulated in the
Quantitative Analyses of Normal Tissue Effects in the Clinic (QUANTEC) are one of the …

Six UK studies investigating stereotactic ablative radiotherapy (SABR) are currently open.
Many of these involve the treatment of oligometastatic disease at different locations in the …

Stereotactic body radiotherapy (SBRT) is a technologically sophisticated form of
radiotherapy that holds significant potential to effectively treat high-risk prostate cancer …

Purpose There is limited data on stereotactic ablative radiation therapy (SABR) in high-risk
prostate cancer (PCa), especially regarding the role of elective nodal irradiation (ENI). This …

Purpose There is no evidence-based data to guide dose constraints in two-fraction prostate
stereotactic ablative radiotherapy (SABR). Using individual patient-data from two …

Purpose Five-fraction stereotactic ablative radiation therapy appears to be gaining
popularity in treatment of prostate cancer, but it has not been extensively tested in the …

Purpose Dose-escalated stereotactic ablative radiotherapy (SABR) to the whole prostate
may be associated with better outcomes but has a risk of increased toxicity. An alternative …

This research aimed to analyze the effect of IFITM 1 on the radioresistance of oral neoplasm.
Using a multi‐group heat map from GSE9716 analysis of the GEO database, IFITM1 was …

Purpose/objectives To report preliminary data on treatment outcome and compliance to
dose-intensified organ sparing SBRT for prostate cancer using a novel electromagnetic …